Skip to content

Repetitive Transcranial Magnetic Stimulation (rTMS) treatment for chronic tinnitus.

Effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS) treatment in patients with chronic tinnitus.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20766
Enrollment
52
Registered
2008-04-23
Start date
2008-04-23
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic tinnitus NL: chronische tinnitus, oorsuizen

Interventions

rTMS: bilateral 1Hz, 110% MT, 2000 stimuli on five subsequent days.

Sponsors

Department of Otorhinolaryngology University Medical Centre Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Chronic, non fluctuating, tinnitus, demonstrated by means of the Diagnostic Protocol Tinnitus UMCU, of at least two months duration. 2. Age >18 years

Exclusion criteria

Exclusion criteria: 1. Treatable cause of the tinnitus 2. Use of anticonvulsant medication or other psychotherapeutic drugs 3. History of epilepsy or family members with epilepsy 4. Presence of active migraine 5. Presence of psychiatric, severe internal or heart diseases or other neurologic diseases besides epilepsy 6. Metal objects in and around body that can not be removed 7. Pregnancy (will be tested on the first day of rTMS using a urine pregnancy test) 8. Alcohol or drug abuse 9. Prior treatment with TMS

Design outcomes

Primary

MeasureTime frame
Tinnitus severity measured with the tinnitus questionnaire

Secondary

MeasureTime frame
- Tinnitus handicap inventory - VAS on burden, loudness, pitch, presence, variability and specific problems in daily life - Beck depression inventory - State trait anxiety index - tinnitus analysis (pitch, loudness, minimal masking level, residual inhibition)

Contacts

Public ContactC.E.L. Hoekstra

University Medical Centre Utrecht Department of Otorhinolaryngology

C.E.L.Hoekstra@umcutrecht.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)